Biohaven Pharmaceutical Holding - Stock Price History | BHVN

Historical daily share price chart and data for Biohaven Pharmaceutical Holding since 2022 adjusted for splits. The latest closing stock price for Biohaven Pharmaceutical Holding as of August 15, 2022 is 148.00.
  • The all-time high Biohaven Pharmaceutical Holding stock closing price was 148.48 on November 03, 2021.
  • The Biohaven Pharmaceutical Holding 52-week high stock price is 151.51, which is 2.4% above the current share price.
  • The Biohaven Pharmaceutical Holding 52-week low stock price is 79.01, which is 46.6% below the current share price.
  • The average Biohaven Pharmaceutical Holding stock price for the last 52 weeks is 129.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biohaven Pharmaceutical Holding Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 103.8729 81.9100 148.4800 64.0700 137.8100 60.79%
2020 62.4714 53.3800 98.2400 27.5100 85.7100 57.44%
2019 47.8562 36.6900 67.0100 34.5200 54.4400 47.21%
2018 33.6381 28.0900 43.0000 22.4900 36.9800 37.06%
2017 27.4828 17.5000 38.2100 17.5000 26.9800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.564B $0.463B
Biohaven Pharmaceutical is a commercial-stage biotechnology company focused on developing, and commercializing products, primarily in the fields of central nervous system diseases, including neurological and rare disorders.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.361B 9.79
GSK (GSK) United Kingdom $73.273B 8.80
Bio-Rad Laboratories (BIO.B) United States $15.412B 34.05
QIAGEN (QGEN) Netherlands $11.336B 18.98
Ginkgo Bioworks Holdings (DNA) United States $6.449B 0.00
Arcus Biosciences (RCUS) United States $1.963B 38.31
Myovant Sciences (MYOV) United Kingdom $1.774B 0.00
Emergent Biosolutions (EBS) United States $1.521B 8.81
Zymeworks (ZYME) Canada $0.430B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Gelesis Holdings (GLS) United States $0.118B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
Ambrx Biopharma (AMAM) United States $0.095B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00